@article{ad7f5772dcb74bb0bfa621b0efd92919,
title = "Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall",
author = "Aung, {Phyu P.} and Naveen Pemmaraju and Torres-Cabala, {Carlos A.} and Madeleine Duvic and Marina Konopleva and Khoury, {Joseph D.} and Prieto, {Victor G.}",
note = "Funding Information: N. P. reports consulting fees and honoraria from AbbVie, Celgene, Stemline, Incyte, Novartis, MustangBio and Roche Diagnostics, LFB; research funding/clinical trials support from Stemline, Novartis, AbbVie, Samus, Cellectis, Plexxikon, Daiichi‐Sankyo, and Affymetrix; and grants/funding from Affymetrix and SagerStrong Foundation. M. K. reports consulting fees/honoraria and research funding/clinical trials support from Stemline Therapeutics. The other authors report no conflicts of interest. Funding Information: The authors thank Ms Stephanie Deming, ELS, Senior Scientific Editor, Scientific Publication Services, Research Medical Library, The University of Texas MD Anderson Cancer Center, for assistance with editing of this manuscript.",
year = "2020",
month = oct,
day = "1",
doi = "10.1111/1346-8138.15456",
language = "English (US)",
volume = "47",
pages = "e354--e355",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "10",
}